The Latin America, Middle East and Africa Veterinary Dermatology Drugs Market would witness market growth of 9% CAGR during the forecast period (2021-2027).
The growth of the veterinary dermatology drugs market is directly proportional to the occurrence of chronic skin diseases. Factors such as rise in demand for farm animal and poultry industry, increasing awareness about several dermatological diseases & treatment methods, supportive government steps towards farm animal production would act as growth catalysts for the overall veterinary dermatology drugs market during the forecasting period.
In addition, animals are highly prone to different kinds of chronic skin diseases. A few skin tumors can be managed with the help of cryotherapy or medical therapy. Many agents like allergens, external irritants, burns, trauma (Viral, bacterial, fungal, other parasitic) can cause different skin diseases. The increase in the number of chronic skin diseases and surging mergers & acquisitions to provide innovative products would boost the growth of the veterinary dermatology drugs market during the forecast years. Furthermore, the overall market is expected to witness new growth avenues due to the increase in awareness among pet lovers and the rise in the number of health checkups.
Brazil is one of the leading countries in the regional veterinary dermatology drugs market due to the high acceptance of pets among the households of this country. Moreover, the aging population that lives alone, having lower interaction with family, combined with financial stability are the catalysts for the adoption rate of pets and the increasing interest in giving appropriate pet drugs, hence supporting the regional veterinary dermatology drugs market.
The main reasons for owning a pet are the increasing number of isolated professionals, the social comfort, security, company, and appealing sense. The growing number of nuclear families is expected to create the desire for pets, which ultimately fuels the demand for veterinary dermatology drugs in the regional market. Therefore, these factors are expected to boost the demand & growth of the regional veterinary dermatology drugs market in the upcoming years.
The Brazil market dominated the LAMEA Livestock Animal Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $226.3 million by 2027. The Argentina market would witness a CAGR of 8.6% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 10.2% during (2021 - 2027).
Based on Route of Administration, the market is segmented into Topical, Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail, Hospital Pharmacies and Online. Based on Drug Indication, the market is segmented into Parasitic Infections, Allergic Infections and Other Indications. Based on Animal Type, the market is segmented into Companion Animal and Livestock Animal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Veterinary Dermatology Drugs Market is Predict to reach $13.6 Billion by 2027, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail
- Hospital Pharmacies
- Online
By Drug Indication
- Parasitic Infections
- Allergic Infections
- Other Indications
By Animal Type
- Companion Animal
- Livestock Animal
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Veterinary Dermatology Drugs Market, by Route of Administration
1.4.2 LAMEA Veterinary Dermatology Drugs Market, by Distribution Channel
1.4.3 LAMEA Veterinary Dermatology Drugs Market, by Drug Indication
1.4.4 LAMEA Veterinary Dermatology Drugs Market, by Animal Type
1.4.5 LAMEA Veterinary Dermatology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Veterinary Dermatology Drugs Market by Route of Administration
3.1 LAMEA Topical Market by Country
3.2 LAMEA Injectable Market by Country
3.3 LAMEA Oral Market by Country
Chapter 4. LAMEA Veterinary Dermatology Drugs Market by Distribution Channel
4.1 LAMEA Retail Market by Country
4.2 LAMEA Hospital Pharmacies Market by Country
4.3 LAMEA Online Market by Country
Chapter 5. LAMEA Veterinary Dermatology Drugs Market by Drug Indication
5.1 LAMEA Parasitic Infections Market by Country
5.2 LAMEA Allergic Infections Market by Country
5.3 LAMEA Other Indications Market by Region
Chapter 6. LAMEA Veterinary Dermatology Drugs Market by Animal Type
6.1 LAMEA Companion Animal Market by Country
6.2 LAMEA Livestock Animal Market by Country
Chapter 7. LAMEA Veterinary Dermatology Drugs Market by Region
7.1 Brazil Veterinary Dermatology Drugs Market
7.1.1 Brazil Veterinary Dermatology Drugs Market by Route of Administration
7.1.2 Brazil Veterinary Dermatology Drugs Market by Distribution Channel
7.1.3 Brazil Veterinary Dermatology Drugs Market by Drug Indication
7.1.4 Brazil Veterinary Dermatology Drugs Market by Animal Type
7.2 Argentina Veterinary Dermatology Drugs Market
7.2.1 Argentina Veterinary Dermatology Drugs Market by Route of Administration
7.2.2 Argentina Veterinary Dermatology Drugs Market by Distribution Channel
7.2.3 Argentina Veterinary Dermatology Drugs Market by Drug Indication
7.2.4 Argentina Veterinary Dermatology Drugs Market by Animal Type
7.3 UAE Veterinary Dermatology Drugs Market
7.3.1 UAE Veterinary Dermatology Drugs Market by Route of Administration
7.3.2 UAE Veterinary Dermatology Drugs Market by Distribution Channel
7.3.3 UAE Veterinary Dermatology Drugs Market by Drug Indication
7.3.4 UAE Veterinary Dermatology Drugs Market by Animal Type
7.4 Saudi Arabia Veterinary Dermatology Drugs Market
7.4.1 Saudi Arabia Veterinary Dermatology Drugs Market by Route of Administration
7.4.2 Saudi Arabia Veterinary Dermatology Drugs Market by Distribution Channel
7.4.3 Saudi Arabia Veterinary Dermatology Drugs Market by Drug Indication
7.4.4 Saudi Arabia Veterinary Dermatology Drugs Market by Animal Type
7.5 South Africa Veterinary Dermatology Drugs Market
7.5.1 South Africa Veterinary Dermatology Drugs Market by Route of Administration
7.5.2 South Africa Veterinary Dermatology Drugs Market by Distribution Channel
7.5.3 South Africa Veterinary Dermatology Drugs Market by Drug Indication
7.5.4 South Africa Veterinary Dermatology Drugs Market by Animal Type
7.6 Nigeria Veterinary Dermatology Drugs Market
7.6.1 Nigeria Veterinary Dermatology Drugs Market by Route of Administration
7.6.2 Nigeria Veterinary Dermatology Drugs Market by Distribution Channel
7.6.3 Nigeria Veterinary Dermatology Drugs Market by Drug Indication
7.6.4 Nigeria Veterinary Dermatology Drugs Market by Animal Type
7.7 Rest of LAMEA Veterinary Dermatology Drugs Market
7.7.1 Rest of LAMEA Veterinary Dermatology Drugs Market by Route of Administration
7.7.2 Rest of LAMEA Veterinary Dermatology Drugs Market by Distribution Channel
7.7.3 Rest of LAMEA Veterinary Dermatology Drugs Market by Drug Indication
7.7.4 Rest of LAMEA Veterinary Dermatology Drugs Market by Animal Type
Chapter 8. Company Profiles
8.1 Merck Group
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Elanco Animal Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.5.2 Product Launches and product Expansions:
8.3 Zoetis, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisitions and Mergers:
8.5 Boehringer Ingelheim International Gmbh
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Vetoquinol SA (Soparfin SCA)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.6.3.2 Acquisitions and Mergers:
8.7 Virbac
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Bioibérica, S.A.U.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Bimeda, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisitions and Mergers:
8.9.2.2 Product Launches and Product Expansions:
8.10. Ceva Santé Animale
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 LAMEA Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 4 LAMEA Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 5 LAMEA Topical Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Topical Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Injectable Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Injectable Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Oral Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Oral Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 12 LAMEA Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 13 LAMEA Retail Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Retail Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Online Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Online Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 20 LAMEA Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 21 LAMEA Parasitic Infections Market by Region, 2017 - 2020, USD Million
TABLE 22 LAMEA Parasitic Infections Market by Region, 2021 - 2027, USD Million
TABLE 23 LAMEA Allergic Infections Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Allergic Infections Market by Country, 2021 - 2027, USD Million
TABLE 25 LAMEA Other Indications Market by Region, 2017 - 2020, USD Million
TABLE 26 LAMEA Other Indications Market by Region, 2021 - 2027, USD Million
TABLE 27 LAMEA Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 28 LAMEA Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 29 LAMEA Companion Animal Market by Country, 2017 - 2020, USD Million
TABLE 30 LAMEA Companion Animal Market by Country, 2021 - 2027, USD Million
TABLE 31 LAMEA Livestock Animal Market by Country, 2017 - 2020, USD Million
TABLE 32 LAMEA Livestock Animal Market by Country, 2021 - 2027, USD Million
TABLE 33 LAMEA Veterinary Dermatology Drugs Market by Region, 2017 - 2020, USD Million
TABLE 34 LAMEA Veterinary Dermatology Drugs Market by Region, 2021 - 2027, USD Million
TABLE 35 Brazil Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 36 Brazil Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 37 Brazil Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 38 Brazil Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 39 Brazil Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 Brazil Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 41 Brazil Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 42 Brazil Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 43 Brazil Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 44 Brazil Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 45 Argentina Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 46 Argentina Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 47 Argentina Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 48 Argentina Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 49 Argentina Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 50 Argentina Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 51 Argentina Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 52 Argentina Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 53 Argentina Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 54 Argentina Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 55 UAE Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 56 UAE Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 57 UAE Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 58 UAE Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 59 UAE Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 60 UAE Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 61 UAE Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 62 UAE Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 63 UAE Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 64 UAE Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 65 Saudi Arabia Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 66 Saudi Arabia Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 67 Saudi Arabia Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 68 Saudi Arabia Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 69 Saudi Arabia Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 70 Saudi Arabia Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 71 Saudi Arabia Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 72 Saudi Arabia Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 73 Saudi Arabia Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 74 Saudi Arabia Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 75 South Africa Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 76 South Africa Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 77 South Africa Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 78 South Africa Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 79 South Africa Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 80 South Africa Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 81 South Africa Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 82 South Africa Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 83 South Africa Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 84 South Africa Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 85 Nigeria Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 86 Nigeria Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 87 Nigeria Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 88 Nigeria Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 89 Nigeria Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 90 Nigeria Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 91 Nigeria Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 92 Nigeria Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 93 Nigeria Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 94 Nigeria Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 95 Rest of LAMEA Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 96 Rest of LAMEA Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 97 Rest of LAMEA Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 98 Rest of LAMEA Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 99 Rest of LAMEA Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 100 Rest of LAMEA Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 101 Rest of LAMEA Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 102 Rest of LAMEA Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 103 Rest of LAMEA Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 104 Rest of LAMEA Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 105 key Information – Merck Group
TABLE 106 Key information – Elanco Animal Health, Inc.
TABLE 107 Key Information – Zoetis, Inc.
TABLE 108 Key Information – Eli Lilly and Company
TABLE 109 Key Information – Boehringer Ingelheim International GmbH
TABLE 110 Key Information – Vetoquinol SA
TABLE 111 Key Information – Virbac
TABLE 112 Key Information – Bioibérica, S.A.U.
TABLE 113 Key Information – Bimeda, Inc.
TABLE 114 Key Information – Ceva Santé Animale
List of Figures
FIG 1 Methodology for the research
FIG 1 Recent strategies and developments: Bioibérica, S.A.U.
FIG 2 Recent strategies and developments: Bimeda, Inc.